| Literature DB >> 34899374 |
Shuai Mu1, Yang Xia2, Qijun Wu2, Chao Ji2, Huixu Dai2, Ming Zhang3, Jiao Jiao4, Feng Shi5, Shengye Liu1, Guangbin Wang1, Tao Shen1, Ye Tian1, Liqing Yang1, Qin Fu1, Yuhong Zhao2.
Abstract
Objective: Both exercise and cold exposure cause physiological stress and they often occur in combination. However, the effects of exercise during severe cold on variation in bone metabolism in humans have remained elusive. The aim of this study was to investigate the variations in circulating bone metabolism markers after ice swimming (IS).Entities:
Keywords: bone (re)modeling markers; bone mineral density; cold exposure; exercise; parathyroid hormone (PTH)
Year: 2021 PMID: 34899374 PMCID: PMC8662563 DOI: 10.3389/fphys.2021.731523
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Baseline characteristics of the study subjects.
|
|
|
|
|
|
| 87 (100) | 72 (82.8) | 15 (17.2) | – | |
| Age, | 0.088 | |||
| 40–55 | 32 (36.8) | 27 (37.5) | 5 (33.3) | |
| 56–65 | 40 (46.0) | 30 (41.7) | 10 (66.7) | |
| ≥66 | 15 (17.2) | 15 (20.8) | 0 (0.0) | |
| BMI, median (Q1–Q3), kg/m2 | 25.6 (24.4–27.9) | 25.6 (24.7–28.1) | 24.3 (23.7–26.9) | 0.263 |
| Smokers, | 21 (24.1) | 21 (29.2) | 0 (0.0) | 0.016 |
| Drinkers, | 45 (51.7) | 45 (62.5) | 0 (0.0) | <0.001 |
| IS distance per session, | 0.848 | |||
| <80 m | 74 (85.1) | 61 (84.7) | 13 (86.7) | |
| ≥ 80 m | 13 (14.9) | 11 (15.3) | 2 (13.3) | |
| IS frequency per week, N (%) | 0.258 | |||
| ≤3 t/w | 16 (18.4) | 11 (15.3) | 5 (33.3) | |
| 4–5 t/w | 27 (31.0) | 23 (31.9) | 4 (26.7) | |
| 6–7 t/w | 44 (50.6) | 38 (52.8) | 6 (40.0) | |
| Total IS years, | 0.188 | |||
| <5 years | 33 (37.9) | 26 (36.1) | 7 (46.7) | |
| 5–9 years | 25 (28.7) | 19 (26.4) | 6 (40.0) | |
| ≥10 years | 29 (33.3) | 27 (37.5) | 2 (13.3) | |
| L1–L4 BMC, mean (SD), g | 67.3 (13.2) | 70.4 (11.8) | 52.8 (9.6) | <0.001 |
| L1–L4 BMD, mean (SD), g/cm2 | 1.0 (0.1) | 1.0 (0.1) | 0.9 (0.2) | 0.002 |
| FN BMC, median (Q1–Q3), g | 4.3 (3.6–4.8) | 4.4 (3.9–4.9) | 3.4 (3.0–3.6) | <0.001 |
| FNBMD, median (Q1–Q3), g/cm2 | 0.8 (0.7–0.9) | 0.8 (0.7–0.9) | 0.7 (0.6–0.8) | <0.001 |
| FRAX HF1, median (Q1–Q3), % | 0.5 (0.2–1.0) | 0.5 (0.2–1.0) | 0.5 (0.3–0.8) | 0.623 |
| FRAX HF2, median (Q1–Q3), % | 0.4 (0.2–0.8) | 0.4 (0.2–0.8) | 0.4 (0.2–1.0) | 0.366 |
| FRAX MOF1, median (Q1–Q3), % | 2.6 (1.8–3.4) | 2.5 (1.8–3.1) | 3.2 (2.5–5.5) | 0.032 |
| FRAX MOF2, median (Q1–Q3), % | 2.5 (1.8–3.9) | 2.2 (1.7–3.6) | 3.6 (2.6–5.6) | 0.007 |
| Pre-IS PTH, median (Q1–Q3), pg/mL | 40.1 (33.0–48.5) | 39.9 (32.1–47.9) | 42.1 (36.0–52.1) | 0.366 |
| Pre-IS Ca2+, median (Q1–Q3), mmol/L | 2.3 (2.3–2.4) | 2.3 (2.3–2.4) | 2.4 (2.3–2.4) | 0.434 |
| Pre-IS Pi, median (Q1–Q3), mmol/L | 1.1 (1.0–1.2) | 1.1 (1.0–1.2) | 1.1 (1.1–1.2) | 0.563 |
| Pre-IS Mg2+, mean ( | 1.0 (0.1) | 1.0 (0.1) | 1.0 (0.1) | 0.908 |
| Pre-IS N-MID, median (Q1–Q3), ng/mL | 13.9 (11.7–17.5) | 13.6 (11.1–16.8) | 16.6 (12.2–19.7) | 0.064 |
| Pre-IS TPINP, median (Q1–Q3), ng/mL | 38.2 (32.1–50.3) | 37.2 (31.2–44.4) | 53.8 (45.9–81.3) | <0.001 |
| Pre-IS β-CTX, median (Q1–Q3), ng/mL | 0.2 (0.1–0.2) | 0.2 (0.1–0.2) | 0.3 (0.2–0.4) | 0.072 |
| ΔPTH, median (Q1–Q3), pg/mL | 11.2 (2.9–20.3) | 10.0 (2.4–18.4) | 16.3 (9.8–21.5) | 0.174 |
| ΔCa2+, mean ( | 0.1 (0.1) | 0.1 (0.1) | 0.1 (0.1) | 0.944 |
| ΔPi, mean ( | 0.2 (0.2) | 0.3 (0.2) | 0.2 (0.1) | 0.065 |
| ΔMg2+, mean ( | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.384 |
| ΔN-MID, median (Q1–Q3), ng/mL | 0.0 (–0.6 to 0.5) | 0.0 (–0.5 to 0.5) | –0.0 (–0.6 to 0.5) | 0.933 |
| ΔTPINP, median (Q1–Q3), ng/mL | –1.9 (–3.8 to –0.1) | –1.5 (–3.2 to 0.0) | –3.6 (–8.8 to –2.5) | 0.005 |
| Δβ-CTX, median (Q1–Q3), ng/mL | –0.0 (–0.0 to 0.0) | –0.0 (–0.0 to 0.0) | –0.0 (–0.0 to 0.0) | 0.445 |
SD, standard deviation; Q1, first quartile; Q3, third quartile; BMI, body mass index; IS, ice swimming; L1–L4, lumbar spine1–4; FN, femoral neck; BMC, bone mineral content; BMD, bone mineral density; FRAX HF1, FRAX predicted probability of hip fracture (without BMD); FRAX HF2, FRAX predicted probability of hip fracture (with BMD); FRAX MOF1, FRAX predicted probability of major osteoporotic fracture (without BMD); FRAX MOF2, FRAX predicted probability of major osteoporotic fracture (with BMD); Pre-IS, the circulating levels before ice swimming; PTH, parathyroid hormone; N-MID, N-terminal osteocalcin; TPINP, total propeptide of procollagen 1; β-CTX, C-terminal crosslaps; Δ, the circulating changes responses to ice swimming.
Variations of bone metabolism characteristics responses to ice swimming.
|
|
|
|
|
|
|
| PTH, median (Q1–Q3), pg/mL | 87 | 40.120 (32.995–48.475) | 51.540 (40.925–66.405) | <0.001 | 11.190 (2.930–20.260) |
| Ca2+, median (Q1–Q3), mmol/L | 87 | 2.330 (2.285–2.380) | 2.400 (2.330–2.465) | <0.001 | 0.060 (0.010–0.110) |
| Pi, median (Q1–Q3), mmol/L | 87 | 1.100 (1.000–1.185) | 1.340 (1.200–1.470) | <0.001 | 0.240 (0.130–0.350) |
| Mg2+, mean ( | 87 | 1.007 (0.060) | 1.016 (0.068) | 0.058 | 0.009 (0.042) |
| N-MID, median (Q1–Q3), ng/mL | 87 | 13.940 (11.705–17.525) | 13.560 (11.470–17.415) | 0.933 | 0.020 (–0.555 to 0.475) |
| TPINP, median (Q1–Q3), ng/mL | 87 | 38.190 (32.110–50.275) | 36.610 (29.485–50.260) | <0.001 | –1.920 (–3.785 to –0.100) |
| β-CTX, median (Q1–Q3), ng/mL | 87 | 0.185 (0.148–0.244) | 0.171 (0.138–0.249) | 0.001 | –0.012 (–0.031 to 0.003) |
SD, standard deviation; Q1, first quartile; Q3, third quartile; IS, ice swimming; PTH, parathyroid hormone; N-MID, N-terminal osteocalcin; TPINP, total propeptide of procollagen 1; β-CTX, C-terminal crosslaps.
The proportional changes of PTH, Ca2+, and Pi responses to IS.
|
|
|
|
|
| |||
|
|
|
|
|
|
| ||
| PTH, | 0(0%) | 0 (0%) | 81 (93.1%) | 61 (70.1%) | 6 (6.9%) | 26(29.9%) | <0.001 |
| Ca2+, | 1(1.1%) | 0 (0%) | 80 (92.0%) | 76 (87.4%) | 6 (6.9%) | 11(12.6%) | 0.034 |
| Pi, | 9(10.3%) | 0 (0%) | 77 (88.5%) | 82 (94.3%) | 1 (1.1%) | 5(5.7%) | <0.001 |
IS, ice swimming; PTH, parathyroid hormone.
The differences in bone metabolism characteristics among the normal bone mass, osteopenia, and osteoporosis groups.
|
|
|
|
|
|
|
| Pre-IS PTH, median (Q1–Q3), pg/mL | 39.61 (34.36–47.82) | 42.70 (33.91–50.59) | 35.12 (28.66–43.92) | 0.614 | 0.098 |
| Pre-IS Ca2+, median (Q1–Q3), mmol/L | 2.32 (2.28–2.35) | 2.33 (2.29–2.38) | 2.38 (2.31–2.49) | 0.114 | 0.011 |
| Pre-IS Pi, mean ( | 1.11 (0.12) | 1.11 (0.20) | 1.06 (0.17) | 0.682 | 0.585 |
| Pre-IS Mg2+, mean ( | 1.00 (0.06) | 1.01 (0.06) | 1.01 (0.06) | 0.899 | 0.692 |
| Pre-IS N-MID, median (Q1–Q3), ng/mL | 12.55 (10.98–14.70) | 14.63 (11.80–17.55) | 17.92 (12.76–21.19) | 0.063 | 0.005 |
| Pre-IS TPINP, median (Q1–Q3), ng/mL | 34.61 (29.29–43.57) | 40.56 (34.69–49.88) | 57.39 (39.46–83.56) | 0.020 | <0.001 |
| Pre-IS β-CTX, median (Q1–Q3), ng/mL | 0.18 (0.16–0.23) | 0.19 (0.15–0.24) | 0.28 (0.15–0.42) | 0.619 | 0.037 |
| ΔPTH, median (Q1–Q3), pg/mL | 11.71 (2.36–20.45) | 9.13 (3.35–17.74) | 17.46 (6.08–25.34) | 0.591 | 0.892 |
| ΔCa2+, mean ( | 0.06 (0.07) | 0.05 (0.07) | 0.10 (0.09) | 0.216 | 0.318 |
| ΔPi, mean ( | 0.21 (0.15) | 0.24 (0.16) | 0.31 (0.16) | 0.222 | 0.092 |
| ΔMg2+, mean ( | 0.01 (0.04) | 0.00 (0.04) | 0.02 (0.03) | 0.267 | 0.628 |
| ΔN-MID, mean ( | 0.00 (0.98) | 0.08 (1.06) | 0.34 (1.07) | 0.663 | 0.406 |
| ΔTPINP, median (Q1–Q3), ng/mL | –1.92 (–3.19 to –0.85) | –1.33 (–3.33 to 0.30) | –5.49 (–11.78 to 0.24) | 0.284 | 0.132 |
| Δβ-CTX, median (Q1–Q3), ng/mL | –0.01 (–0.02 to 0.00) | –0.02 (–0.04 to 0.00) | –0.01 (–0.02 to 0.04) | 0.457 | 0.984 |
SD, standard deviation; Q1, first quartile; Q3, third quartile; Pre-IS, the circulating levels before ice swimming; PTH, parathyroid hormone; N-MID, N-terminal osteocalcin; TPINP, total propeptide of procollagen 1; β-CTX, C-terminal crosslaps; Δ, the circulating changes responses to ice swimming.
FIGURE 1Correlations between ΔPTH and bone metabolism biomarkers. (A) Positive correlation between ΔPTH and Pre-IS Mg2+; (B) negative correlation between ΔPTH and ΔCa2+; (C) positive correlation between ΔPTH and ΔPi; (D) negative correlation between ΔPTH and ΔMg2+.
Correlations of bone metabolism biomarkers.
|
|
|
|
|
|
|
|
|
| Pre-IS PTH, (pg/mL) | 0.0473 | 0.0321 | −0.2144 | –0.0331 | –0.0816 | −0.2130 | –0.0488 |
| Pre-IS Ca2+, (mmol/L) | 0.1584 | –0.1774 | 0.3022 | –0.1075 | 0.2598 | 0.1688 | 0.1507 |
| Pre-IS Pi, (mmol/L) | –0.0722 | –0.1062 | −0.3824 | –0.0437 | 0.1197 | 0.0124 | 0.2151 |
| Pre-IS Mg2+, (mmol/L) | 0.3909 | –0.0023 | 0.2377* | –0.1176 | 0.1148 | 0.1725 | –0.0286 |
| Pre-IS N-MID, (ng/mL) | 0.0494 | –0.1190 | 0.0117 | –0.1429 | 0.1499 | –0.0813 | 0.1368 |
| Pre-IS TPINP, (ng/mL) | –0.0869 | –0.0862 | –0.1203 | –0.0460 | 0.1522 | −0.2539 | 0.2298* |
| Pre-IS β-CTX, (ng/mL) | 0.0624 | 0.0333 | –0.0486 | 0.0304 | –0.0639 | −0.2508 | −0.2503 |
| ΔCa2+, (mmol/L) | −0.2444 | – | – | – | – | – | – |
| ΔPi, (mmol/L) | 0.3651 | 0.2102 | – | – | – | – | – |
| ΔMg2+, (mmol/L) | −0.3691 | 0.6022 | 0.0703 | – | – | – | – |
| ΔN-MID, (ng/mL) | 0.1087 | –0.0450 | –0.0388 | 0.1340 | – | – | – |
| ΔTPINP, (ng/mL) | 0.1771 | –0.1436 | 0.1156 | –0.0028 | 0.5210 | – | – |
| Δβ-CTX, (ng/mL) | 0.0879 | –0.1674 | –0.0587 | –0.0629 | 0.4963 | 0.2525 | – |
Pre-IS, the circulating levels before ice swimming; PTH, parathyroid hormone; N-MID, N-terminal osteocalcin; TPINP, total propeptide of procollagen 1; β-CTX, C-terminal crosslaps; Δ, the circulating changes responses to ice swimming; the